: *
!" # $ %&%' ( .
*+
:,& " - ! [email protected]
٢
،
*١
1 - ! " # $ % &' .
2 - )*+
, $- .
.
! / #
$%&
/ ' !
4 /
$ ) 97
,$ $ / 78
: 29 / 7 / 97 :
12 / 9 / 97
:
. ! " #$% & ' ( ) * +& , -
+ . 42 . 1 2 3 % 4 ' ( 567 4 89 : ; %
5 / 3 ? ? : @ A ' -? ;?
,?'B CD? . ? 1E ? ? F ? ; % ? ,? A ?7 G ,? H ) ,I% . 4 G J ,?6K BK
L M ; N7 B : + G ( * -?A O '? ?P J( ; %
. ? Q C: ?( R?:
5?
L 8 , A ) : - ( . ". ; %
4S :G ' G E
.; % T ' ( TG , H
% $ / 0% 1 2! # 3 ! % .!4 % 35&$ 6 4 7!8! # 9 :
8!$
;% < <= )!<'- ; 5$ % 2! # 3 ! % .!4 > <?$ 7!8@.= 3 ! 2' A 54 , = A ' . = % .38&C= !'
D &8# E% , F!G % H8$ 24 - IH8$ A
<$ ;% < , ! ! &J K ' A< 3< 4
<=
.!L34 : <?$ <= % L I! &C$ 2&!C!C# =
2<M 4 .3 4 $ ;% 7 &. $ 7 &5 M - <= !<' ' . <= % 9= <# 9 <: 2 8
.!4
<$ # 3= L % N&$ % %
<+ O < $ 3<
*P 24 - I!H8 Q .38# R S 5$ / 4 TO
.A' 6 $ % !C4 U! 2V 7 % 4 A# J
9 <<: <<4 2<<# 2<<! # 3<< ! % <<.!4 << , 0% <<1 %
% < , A 54 V 4 , 354 # 25M $ 7!8! # %
$ % W X 3R$ $%
.I!8# $ T *$ $ 6
* Q -A
I L 42 % &C4 , 6V+ $ % W 2# 2 ' ,
- 6<# E ' 4 3 2! # 3 ! > Z =% #
) 7 ! ,- 6$ !' ' . = % # $
50
!$
7 % ^' !' (, % % % 4 1 100
<4 1 !$
%
! , % % 15
<$ A<: % , % % <1 < !$
% .!4 2 7!8! # .A' # 9
/ 0 <' % <1 < !$
7!8! <# 2<# <!L 9 <$,- 24 2M 4 A' 4 &!
5 / 3 % &<C4 2<4 2!P 2& &! ' % 1 !$
. 4 3 # $ 7
2<4 /< % % IcO 24 2M 4 &C4 3&4 % A 3< D '% % % ! - A # $,- % % 9 <$,- $ .= .3 , d- I8 $ 4 ! !4 & - $%
E < E $ &!' A '% 4 24 e 4 $
BK
f*<<<' .3<<< D <<<'% <<<! 7 % ^<<<' !' f*<<<' g3< 0% 1 h 4 7 % ^' !'
C0:250 C2:650
Q<
24 7 % ^' !' !$
75 - 100 2<$ <4 .A<: 9= #
% 7!8! <# < $% 24 j' ! !4 & - $%
2<4 X & 4 A: D J 5
/ 1 <&! <' % <1 < !$
k M $, 7 % .3!'%
<L % E BK
105
%
8 % % 10 2<4 , <8= 7!8! <# 2 8 24 2M 4 .3 O
.$ 4 3!' V+ D $ 3J
A , M% 4 7
7< ' . 9= <# 3< 4 2!<N+ 7< m 4 ! BK
n 3<54 7!8! <# .3< R % .!4 4IVIG
3 / 1
<<1 << !$
% 9= <<# D V 3<<4 << <<4 <<&! <<'
! ) 7 ' .
5 7 <! ,- K*+ 1 !$
7 % ^' !' 50
% % (, % % % <4 1 !$
<=,
24 7!8! # X 3R$ 354 5
/ 1 o^' 7 / 1 2 1 !$
9= <<# A<< 54 7<< R % D <<.&J .3!<<'% <<&! <<' % <<p << % % A<< << << 7<< ' .
BK
2<# 3< <R % % ! - A # .A M 3 D '% 24 2# 2! # C !4 2 . 4 8$
J % 3 0% 1 %h ' 2<# % % <'BK
3<R$
. 3 % &! 9 : 3 /W
I<# , 4 ! 6!&$ o % .!4 4 Q 250
A 54) 1 !$
3 &$ , % 2' % (AVq$BK
7 <& ,- .3< & !4 % .!4 !' ' . = % 50
, % % % <4 <1 !$
< ! 15 <1 < !$
7 % ^' !' 75
- 100 V< L % .!4 7!8! # .3 2 &G
X & # 9= # 24 n 24
9 / 0 9= # o^' 3!'%
! 6$ 7 ' . 2&C=- 5
/ 12 1 !$
o^<<<' 3 7 <<<! , 3<<<54 , % 25
- 50 3 4 , % 3<<<5
7 % ^' !' 75
- 75 8@.= 7!8! # .3 R 9
/ 0
9= <# 2<$ <' % <*4 < 3< FL $ % .!4 4
9= # % H8$ 24 7 ' .
. R $ BK
UI
)< $ % <*4 2<# A<' , <! 2<! # 3< ! % .!4 % 2<4 <&4 < < <R r <?G$ 8 5$ $,-
% $ / 0% 1 2! # 3 ! % .!4 % 35&$ 6 4 7!8! # 9 :
8!$
3<+ < - K<:% A< M % 3<! % - O $ A ' - , . # f*<' < <$ <R X % < $ 2# $,
<&4 - 9 <: % P % A' 7!8! # .'O 7< .$ 7!8! <# 9 : A . # $% A: % A 3 4 3 ! % 2R!& % 7 ' . 9= # A' <<= % , << &!<<C!C# 7<< ' . 9 <<:
# <<= 3<<88# % << $ r <<?G4 6$ << 2<<# 7 % << <<C
A' E .! # 7 % ^' !' )
1 2 ( % $ 7 2#
%
f*' '% 4 4
<$ FG< $ 2<! # <C !4 R %
A 6$ 7!8! # 9 : 4 6 ' 2&V .I!8#
A< 2<! # 3< ! % < - 7 <&. $ 2# s &G$ = E $ &!' % %
<4 .38&<C=BK
A<
3&4 , 2 ! ! $% E $ &!' % % - I<d% < $ R P L $, 3 !
3 = t = A 7 A' 7 .$
) 3 % % A< .(
A<' I< $ K < 2<! # 3 ! , 354 D $ 9 %
< <$% h <Z 3<M % <Z 2<4 3< 4 )
4 &!<' .(
$ % A 7!8! # 9 : m 4 3 &!$ E 2<# < <= % 3V# 2 % 6q$ !J 1% '
% L r L ;% 3# =
% ) 5 .(
<$ ! <! BK
<' % A' 3 ! 2! # r ?G$ 2# A' ' 2<# % % I&<C!' % K+ % .I!&C! - =3 !
f*' % !<' ' . <= % A< 54 8! 8.
<+ 7< ' . % <P % $ % 3 3 <&J
$ 3< <$ 2<# A<' $, - 34 % L 24 3 3< ! 2<! # A<: 4 < % V4 h 4 % 7!8! # 7 <&. $ % 3< V<' 8$ <$% 2 <' &$ . 3
< 2# $%
<
3< 2<&: 1 <H % - <4 <$, 7
) A' % .!4 7 ' . 9= #
6 ! <= % , 2<&V .(
!$ &' % $ 7 % ! 3 $ 6q$
<W
% % f*<' I!H8 24 , !
&<' 6<4 + <&J % 2<4
E $ &!<<' A<<!.= 2<<4 2<<M <<4 .A<<C!
BK
- % $,-
<4 < A' 3 2!P % .!4 %
% <*4 %3<84 < $,- 7 R h 4 28 = 24 2M ) $ R 7! % 7
.(
Q<<
E << 7<<
9 <<: , 3<<54 % <<$ )<< d % <<=
j<' D <.&J $, 7 % .3 $ /W 7!8! # , 6<V+ % < - 2<# A<' <$, , <&.# $% 24 =
# 9 : .I!8# 3! 7!8!
2<M &$ % < $,- D V 3<4 <! % .!4 7 % <<< $,- o^<<<' 3<<< 7!8! <<<# 9 <<<:
BK
% < $ f*<' % % A< # ! - E $ &!' A $% , 354 A' 3 /W 7 % C # 388#
2<4 2M 4 $% 24 j' % % <L % A<Vq$BK
) 104 < 3< R !' ' . = % 9= # (>
% % <W % <.!4 7< ' . 3<J , , 9= # A 54 % <<$ % .A<' 3<< 7!8! <# 3<<R$ 9 <: 3< ! 2&<C=- 9= <# 24 3!# !' ' . = % 9= # 2& 1 &J . !1 M 3 ! % , A' - R %3
= % $ <= % , < , v< : % <.!4 A
9= <<# % <<$ % . <<# I<<# << <<$ % !<<' ' . 9= <# 2<4 , R$ v : % 4 = 2# 3 2& 1 7 % ^' !'
25 % <P % 7< 4 O .I! 4 $ % , , 3P%
M J 3 ! % , 4 % <$% <$ .= AVq$BK
h <<4 , , &<<' <<4 3<< ! <<! 3!c &<<' ! % #
3 3< D .&J A' w *L . % <M <$ BK
3 ! J % $ .= 2# $% , $ BK
, &' $ T *$
2# 7 24 2M 4 .A' IVIG
3= $ D V 34 % .!4 7 <# A<: % % - $ BK
% .!4 7 % $ % 2&V .A 3 M % 24 $ 4 3< ! % D <.&J <R4 7!8! <# 3R$ 9 : D V 34 D .&J <4 T *$ ! % % A BK
3<R$ <!1 , 3< % % A # ! - 24 2M 4
% $ / 0% 1 :
2! # 3 ! % .!4 % 35&$ 6 4 7!8! # 9
8!$
&!
% 2 8 BK
, <p ! 2! # C !4 2 .
BK
.3 % h .&J ' 3 0% 1 %
, TO<P 3 ! % $% 4 x : % .!4 2 &GV L D <$ 7!8! <# 4 3 $% !' ' . = %
. 3 FL $
% $ / 0% 1
# 9 : 2! # 3 ! % .!4 % 35&$ 6 4 7!8!
8!$
References
1. Azarfar A, Ravanshad Y, Mehrad-Majd H, Esmaeeli M, Aval SB, Emadzadeh M, et al.
Comparison of tacrolimus and cyclosporine for immunosuppression after renal transplantation: An updated systematic review and meta-analysis. Saudi J Kidney Dis Transpl. 2018 Nov-Dec;29(6):1376- 1385.
2. Penninga L, Møller CH, Gustafsson F, Steinbrüchel DA, Gluud C. Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomised trials. Eur J Clin Pharmacol.
2010 ;66(12):1177-1187.
3. Kotagiri P, Chembolli D, Ryan J, Hughes PD, Toussaint ND. Urinary Tract Infections in the First Year Post-Kidney Transplantation: Potential Benefits of Treating Asymptomatic Bacteriuria.
Transplant Proc. 2017 Nov;49(9):2070- 2075.
4. Gołębiewska JE, Dębska-Ślizień A, Rutkowski B. Treated asymptomatic bacteriuria during first year after renal transplantation. Transpl Infect Dis. 2014 Aug;16(4):605-615.
5. Boan P, Swaminathan R, Irish A. Infectious complications in indigenous renal transplant recipients in Western Australia. Intern Med J. 2017 Jun;47(6):648-655.
6. Devresse A, Tinel C, Vermorel A, Snanoudj R, Morin L, Avettand-Fenoel V, et al. No clinical benefit of rapid vs gradual tapering of immunosuppression to treat sustained BK virus viremia after kidney transplantation: a single-center experience.
Transpl Int. 2018 Dec 19. doi:
10.1111/tri.13392.
7. Sood P, Senanayake S, Sujeet K, Medipalli R, Zhu YR, Johnson CP, et al. Management and outcome of BK viremia in renal transplant recipients: a prospective single- center study. Transplantation. 2012 Oct 27;94(8):814-821.
% $ / 0% 1 2! # 3 ! % .!4 % 35&$ 6 4 7!8! # 9 :
8!$
Report of increased creatinine with more than one etiology in a kidney transplanted disease
Minoo Fs1,2*
1. Assistant Professor of Nephrology, Nephrology Research Center, Tehran University of Medical Science, Tehran, Iran, [email protected].
2. Center of Excellence in Nephrology, Tehran University of Medical Science, Tehran, Iran
Received: 21 Oct 2018 Accepted: 3 Dec 2018
Abstract
Background: Kidney transplant patients should be regularly visited to prevent complications.
A 42-year old female, who had received a kidney transplant 4 months previously, was admitted to hospital due to increased creatinine of up to 3.5 mg/dl. She was first treated for a urinary infection, resulting in a decrease of creatinine level. Then a decreasing immunosuppressive dose was given, due to a BK positive result. A creatinine level increase resulted, and acute cellular rejection was reported in a kidney biopsy. Next methyl prednisolone was administered, and finally, creatinine level became normal.
Keywords: Urinary infection, Kidney transplantation, Creatinine
*Citation: Minoo Fs. Report of increased creatinine with more than one etiology in a kidney transplanted disease.
Yafte. 2019; 20(4):8-13.